MedPath

LETYBO

LETYBO

Approved
DIN Number

02528142

Drug Class

Human

Market Date

Jun 20, 2023

Company
HC

hugel canada inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02528142
AIG Number0163821002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D ,  Prescription
A
ATC Code
M03AX01 BOTULINUM TOXIN
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntramuscular
AHFS Classification12:20.20.24
Health Canada Classification

ACTIVE INGREDIENTS (1)

LETIBOTULINUMTOXINAActive
Strength: 100 UNIT / VIAL
Monograph: LETIBOTULINUMTOXINA

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.